iRobot 2013 Annual Report Download - page 38

Download and view the complete annual report

Please find page 38 of the 2013 iRobot annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 128

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128

32
Outstanding Equity Awards at Fiscal Year End
The following table sets forth, for each of the named executive officers, information about unexercised option awards and other
unvested equity awards that were held as of December 28, 2013. As of December 28, 2013, Mr. Leahy did not hold any outstanding
unexercised stock options or other unvested equity awards.
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END — 2013
Option Awards Stock Awards
Name Grant Date
Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
(1)
Option
Exercise
Price
($)
Option
Expiration
Date
Number of
Shares or
Units of Stock
That Have
Not Vested
(#)(2)
Market Value of
Shares or
Units of Stock
That Have Not
Vested
($)(3)
Colin M. Angle 5/25/2007 21,333 — 16.03 5/25/2014 — —
3/28/2008 26,000 — 17.13 3/28/2015 — —
2/20/2009 73,829 — 7.76 2/20/2016 — —
4/2/2010 99,707 14,243 14.52 4/2/2017 7,562 267,770
4/1/2011 28,250 16,950 33.48 4/1/2018 11,400 403,674
3/9/2012 17,862 22,963 26.59 3/9/2019 60,937 2,157,779
3/8/2013 — 36,175 22.86 3/8/2020 66,250 2,345,913
Alison Dean 7/27/2007 416 — 18.74 7/27/2014 — —
7/25/2008 1,873 — 14.09 7/25/2015 — —
4/2/2010 9,625 1,375 14.52 4/2/2017 725 25,672
4/1/2011 4,610 2,765 33.48 4/1/2018 1,862 65,933
3/9/2012 2,068 2,657 26.59 3/9/2019 7,050 249,641
3/8/2013 — 4,975 22.86 3/8/2020 9,100 322,231
6/7/2013 — 8,475 34.67 6/7/2020 14,800 524,068
Russell J. Campanello 12/30/2010 28,750 31,250 24.53 12/30/2017 17,500 619,675
3/9/2012 2,406 3,094 26.59 3/9/2019 15,712 556,362
3/8/2013 — 6,450 22.86 3/8/2020 11,825 418,723
Paolo Pirjanian 10/1/2012 (4) 9,306 17,993 4.81 6/11/2022 — —
10/1/2012 (4) 2,212 1,622 3.54 5/6/2021 — —
12/7/2012 25,000 75,000 18.47 12/7/2019 22,500 796,725
3/8/2013 — 6,450 22.86 3/8/2020 11,825 418,723
Glen D. Weinstein 5/25/2007 3,500 — 16.03 5/25/2014 — —
4/2/2010 20,825 2,975 14.52 4/2/2017 1,575 55,771
4/1/2011 7,110 4,265 33.48 4/1/2018 2,874 101,768
3/9/2012 2,549 3,276 26.59 3/9/2019 8,681 307,394
9/7/2012 1,727 3,798 25.99 9/7/2019 8,231 291,460
3/8/2013 — 6,450 22.86 3/8/2020 11,825 418,723
Jeffrey A. Beck (5) 4/2/2010 4,031 — 14.52 4/2/2017 — —
4/1/2011 3,351 — 33.48 4/1/2018 — —
3/9/2012 2,850 — 26.59 3/9/2019 — —
9/7/2012 3,150 — 25.99 3/9/2019 — —
3/8/2013 3,357 — 22.86 3/8/2020 — —
(1) Stock option grants vest over a four-year period, at a rate of twenty-five percent (25%) on the first anniversary of the grant, and
the remainder in equal quarterly installments thereafter.
(2) Restricted stock unit awards vest over a four-year period, at a rate of twenty-five percent (25%) on each anniversary of the grant.
(3) Amounts disclosed in this column were calculated based on the fair market value of our common stock.
(4) The stock options granted to Dr. Pirjanian on October 1, 2012 were granted as replacement awards for unvested stock options
that Dr. Pirjanian held in Evolution Robotics, Inc. as of the date that the Company acquired Evolution Robotics, Inc.
(5) Mr. Beck’s employment with the Company terminated on December 27, 2013 and pursuant to the Separation Agreement, the
vesting of 9,219 shares of common stock underlying Mr. Beck’s stock options was accelerated and the remaining shares
underlying his unvested stock options were forfeited.